Suchergebnisse - "Langer, Jakob"

PubPharm (17)

1

Developing a health economic model for Asians with type 2 diabetes based on the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial

enthalten in: BMJ open diabetes research & care | 2021

von Tanaka, S. | Langer, J. | Morton, T. | +10

2

A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice : The JAGUAR Study

enthalten in: Advances in therapy | 2021

von Kaneko, S. | da Rocha Fernandes, J. | Yamamoto, Y. | +2

3

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs : Results from a Japanese cohort study (JDDM53)

enthalten in: Journal of diabetes investigation | 2021

von Maegawa, H. | Ishigaki, Y. | Langer, J. | +3

4

Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes : A Discrete Choice Experiment

enthalten in: Advances in therapy | 2021

von Igarashi, A. | Bekker Hansen, B. | Langer, J. | +4

5

Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan : A Short-Term Cost-Effectiveness Analysis

enthalten in: Advances in therapy | 2020

von Igarashi, A. | Hunt, B. | Wilkinson, L. | +2

6

Long-term cost-effectiveness analysis shows that IDegLira is associated with improved outcomes and lower costs compared with insulin glargine U100 plus insulin aspart in the US

enthalten in: Journal of medical economics | 2018

von Dempsey, M. | Mocarski, M. | Langer, J. | +1

7

Ideglira is Associated With Improved Short-Term Clinical Outcomes and Cost Savings Compared with Insulin Glargine U100 Plus Insulin Aspart in the U.S

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2018

von Dempsey, M. | Mocarski, M. | Langer, J. | +1

8

Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes

enthalten in: Journal of managed care & specialty pharmacy | 2018

von Mocarski, M. | Yeaw, J. | Divino, V. | +4

9

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

enthalten in: Advances in therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

ErratumIn: Adv Ther. 2017 Jun;34(6):1500-1501. - PMID 28523624

10

Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States

enthalten in: Journal of medical economics | 2016

von Durden, E. | Lenhart, G. | Lopez-Gonzalez, L. | +2